Skip to main content
Englewood Lab, Inc. logo

Englewood Lab, Inc. — Investor Relations & Filings

Ticker · 950140 ISIN · KR8840110108 KO Manufacturing
Open in API
Filings indexed 211 across all filing types
Latest filing 2024-03-21 Audit Report / Informat…
Country US United States of America
Listing KO 950140

About Englewood Lab, Inc.

http://englewoodlab.com

Englewood Lab, Inc. is a contract manufacturer specializing in the research, development, and production of cosmetic products. The company focuses primarily on skincare and Over-the-Counter (OTC) formulations, offering a diverse portfolio that includes creams, serums, cleansers, masks, and hybrid beauty products. It provides comprehensive services to a global client base, encompassing formulation, stability testing, package compatibility, and full-scale manufacturing. The company's approach is centered on innovation through scientific research, adherence to stringent global quality control standards, and fostering trusted partnerships via transparent communication and client collaboration throughout the development process.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from a Korean company (Ingwood Lab) titled 'Audit Report Submission' (감사보고서 제출). It provides a summary of financial data, audit opinions, and key financial metrics for the fiscal year. According to the 'Menu vs Meal' rule, this is a standard regulatory disclosure announcement regarding the filing of an audit report, which is a common practice in the Korean DART system. Since it is a formal regulatory announcement of the report's submission rather than the full audit report document itself, it is classified as a Report Publication Announcement. FY 2023
2024-03-21 Korean
사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the fiscal year 2023 (Jan 1, 2023 to Dec 31, 2023) filed by Englewood Lab, Inc. to the Financial Services Commission and the Korea Exchange. It contains comprehensive financial data, business operations, management information, and governance details. This aligns with the definition of an Annual Report (10-K) in the provided schema, as it is the official yearly report covering company activity and full financial performance. FY 2023
2024-03-21 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company 'Englewood Lab'. It outlines the date, location, agenda items (such as financial statement approval, director appointments, and remuneration limits), and board resolution details. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon.
2024-03-14 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted by 'Englewood Lab' regarding the scheduling of their Annual General Meeting (AGM) on a 'concentrated date' (a date where many companies hold their AGMs). It explains the operational reasons for choosing this date and provides the meeting details. Since it is a regulatory notification regarding meeting logistics rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2024-03-14 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Englewood Lab, Inc. It contains the agenda for the upcoming annual general meeting, including voting items such as financial statement approval, director appointments, and remuneration limits. It also includes proxy solicitation materials (the 'Application for Exercise of Voting Rights') and governance information (director activity reports). While it contains financial data, this is provided as part of the meeting materials for shareholder review, not as a standalone annual report or earnings release. Therefore, it is classified as Proxy Solicitation & Information Statement.
2024-03-14 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Englewood Lab) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (KRX) when financial results deviate significantly from the previous period. It provides key financial highlights (revenue, operating profit, net income) and the reasons for the change, which aligns with the definition of an Earnings Release (ER). FY 2023
2024-02-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.